文献速递母胎医学产科

颈项透明层增厚且染色体微阵列正常的丹麦全国队列研究

Increased nuchal translucency thickness and normal chromosomal microarray: Danish nationwide cohort study.
PubMed 文献 · Ultrasound Obstet Gynecol · 2025-02-27

丹麦全国注册队列研究纳入2008—2018年557896例单胎妊娠,评估颈项透明层增厚且染色体微阵列正常者的妊娠结局。颈项透明层≥3.5 mm者3717例(0.7%),染色体异常患病率随厚度增加从21%升至69%;染色体微阵列正常者活产无异常率从87%降至29%,且染色体微阵列正常相比传统核型正常未实质改善预后。

要点

  • 颈项透明层≥3.5 mm者染色体异常患病率随厚度增加而升高,3.5-4.4 mm为21%,≥6.5 mm为69%。
  • 颈项透明层增厚且染色体微阵列正常者,无异常活产率从3.5-4.4 mm的87%降至≥6.5 mm的29%。
  • 2014—2018年染色体微阵列使用增加仅轻度提高亚微观异常检出,未实质改善预后。

核心结论

  • 研究重申颈项透明层增厚与染色体异常相关,染色体微阵列虽提高诊断分辨率,但正常结果未实质影响无异常活产率。
  • 作者指出随着全基因组测序在产前保健中日益采用,持续需要准确的临床指导和继续研究。

研究设计与样本

  • 丹麦全国注册队列研究,纳入2008—2018年因早孕期联合筛查就诊的所有单胎妊娠。
  • 颈项透明层厚度与妊娠结局数据来自丹麦胎儿医学数据库,细胞遗传与分子核型数据来自丹麦细胞遗传中心注册库。
  • 共识别557896例有颈项透明层测量且登记结局数据的妊娠,其中3717例(0.7%)颈项透明层≥3.5 mm,3368例(91%)接受遗传学检查。

主要发现

  • 颈项透明层≥3.5 mm者染色体异常患病率从3.5-4.4 mm组的21%升至≥6.5 mm组的69%。
  • 各颈项透明层增厚亚组中,21、18、13三体占所诊断染色体异常的大多数(范围61-87%)。
  • 颈项透明层增厚且染色体微阵列正常者,无异常活产率从3.5-4.4 mm组的87%降至≥6.5 mm组的29%。
  • 2014—2018年相比2008—2012年染色体微阵列使用增加(使用比例分别>60%和<3%)轻度提高亚微观异常检出,但染色体微阵列正常相比传统核型正常未实质改善颈项透明层增厚妊娠的预后。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the outcome of pregnancies with increased fetal nuchal translucency (NT) thickness and a normal result from chromosomal microarray (CMA) vs conventional karyotyping. METHODS: This was a Danish nationwide registry-based cohort study of all singleton pregnancies seen for combined first-trimester screening between 2008 and 2018. Data on NT thickness and pregnancy outcome were retrieved from the Danish Fetal Medicine Database, whereas data on cytogenetic and molecular karyotypes were retrieved from the Danish Cytogenetic Central Register. Pregnancies were stratified according to NT thickness, and we computed the prevalence of chromosomal aberration, termination of pregnancy (due to non-genetic abnormal findings aside from increased NT), pregnancy loss, major congenital malformation and unaffected live birth (live birth ≥ 24 weeks' gestation with no chromosomal aberration or major congenital malformation diagnosed). The prevalence of the different outcomes was further estimated for pregnancies with increased NT (≥ 3.5 mm) and a normal CMA result. Finally, to assess the impact of CMA compared with conventional karyotyping for increased NT, we compared the prevalence of chromosomal aberrations and each pregnancy outcome between the periods 2008-2012 and 2014-2018 (during which < 3% and > 60%, respectively, of pregnancies with increased NT were examined using CMA). RESULTS: We identified 557 896 pregnancies with a NT measurement for which outcome data were registered. Fetal NT was ≥ 3.5 mm in 3717 (0.7%) pregnancies, of which 3368 (91%) underwent genetic examination. The prevalence of chromosomal aberrations increased significantly with increasing NT thickness, from 21% in pregnancies with NT of 3.5-4.4 mm to 69% in pregnancies with NT ≥ 6.5 mm. Trisomies 21, 18 and 13 accounted for the majority of chromosomal aberrations diagnosed in all subgroups of increased NT (range, 61-87%). In pregnancies with increased NT and a normal CMA result, the prevalence of unaffected live birth decreased significantly from 87% for NT of 3.5-4.4 mm to 29% for NT ≥ 6.5 mm. Increased uptake of CMA during 2014-2018 compared with 2008-2012 slightly increased the detection of submicroscopic aberrations. However, a normal CMA result, compared with a normal result from conventional karyotyping, did not substantially improve the prognosis in pregnancies with increased NT. CONCLUSIONS: Our study reaffirms the association between increased NT and chromosomal aberrations. Although CMA improves diagnostic resolution in pregnancies with increased NT, a normal test result does not substantially impact the prevalence of unaffected live births. This highlights the ongoing need for accurate clinical guidance and continued research, especially as whole-genome sequencing is increasingly adopted in prenatal care. © 2025 The Author(s). Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Gadsbøll K, Brix N, Sandager P, et al. Increased nuchal translucency thickness and normal chromosomal microarray: Danish nationwide cohort study. Ultrasound Obstet Gynecol. 2025. PMID: 40017000. doi:10.1002/uog.29198

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。